Abstract
The fundamental role of the inflammatory activation in the pathophysiology of atherosclerosis is now widely established. Different strategies for positive modulation of these processes have been proposed, but the clinical results have been contradictory and sometimes, due to safety issues, a specific therapeutic approach has been withdrawn before reaching the final acceptation of the regulatory agencies. The reasons for these negative conclusions can be multiple and not always completely clarified. In addition it is frequently difficult to separate the metabolic or cardiovascular effects of these approaches (i.e., hypocholesterolemic, hypoglycemic, hypotensive) from the real anti-inflammatory effects. The present review discusses the effects of different anti-inflammatory strategies developed in the last decade for the treatment of atherosclerosis, and consequently for the prevention of cardiovascular events. The complexity of the inflammatory network, well represented by the presence and the action of a plethora of cells and molecules, suggests a word of caution in the evaluation of the clinical results about significant improvements of the atherosclerotic burden: only randomized controlled trials with cardiovascular hard end points can give the final answer.
Keywords: Atherosclerosis, cardiovascular events, cardiovascular prevention, cholesterol, C-reactive protein, inflammation, metabolic or cardiovascular effects, hypocholesterolemic, hypoglycemic, hypotensive, anti-inflammatory effects, anti-inflammatory strategies, plethora of cells, atherosclerotic burden, with cardiovascular hard end points
Current Pharmaceutical Biotechnology
Title: Anti-Inflammatory Approaches to Reduce Acute Cardiovascular Events: Not Only Benefits
Volume: 13 Issue: 1
Author(s): Aldo Pende and Franco Dallegri
Affiliation:
Keywords: Atherosclerosis, cardiovascular events, cardiovascular prevention, cholesterol, C-reactive protein, inflammation, metabolic or cardiovascular effects, hypocholesterolemic, hypoglycemic, hypotensive, anti-inflammatory effects, anti-inflammatory strategies, plethora of cells, atherosclerotic burden, with cardiovascular hard end points
Abstract: The fundamental role of the inflammatory activation in the pathophysiology of atherosclerosis is now widely established. Different strategies for positive modulation of these processes have been proposed, but the clinical results have been contradictory and sometimes, due to safety issues, a specific therapeutic approach has been withdrawn before reaching the final acceptation of the regulatory agencies. The reasons for these negative conclusions can be multiple and not always completely clarified. In addition it is frequently difficult to separate the metabolic or cardiovascular effects of these approaches (i.e., hypocholesterolemic, hypoglycemic, hypotensive) from the real anti-inflammatory effects. The present review discusses the effects of different anti-inflammatory strategies developed in the last decade for the treatment of atherosclerosis, and consequently for the prevention of cardiovascular events. The complexity of the inflammatory network, well represented by the presence and the action of a plethora of cells and molecules, suggests a word of caution in the evaluation of the clinical results about significant improvements of the atherosclerotic burden: only randomized controlled trials with cardiovascular hard end points can give the final answer.
Export Options
About this article
Cite this article as:
Pende Aldo and Dallegri Franco, Anti-Inflammatory Approaches to Reduce Acute Cardiovascular Events: Not Only Benefits, Current Pharmaceutical Biotechnology 2012; 13 (1) . https://dx.doi.org/10.2174/138920112798868539
DOI https://dx.doi.org/10.2174/138920112798868539 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
Latest Advancements in Biotherapeutics
The scope of this thematic issue is to comprehensively explore the rapidly evolving landscape of biotherapeutics, emphasizing breakthroughs in precision medicine. Encompassing diverse therapeutic modalities, the issue will delve into the latest developments in monoclonal antibodies, CRISPR/Cas gene editing, CAR-T cell therapies, and innovative drug delivery systems, such as nanoparticle-based ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Immune System Regulation in Sepsis: From Innate to Adaptive
Current Protein & Peptide Science Angiotensin II-Vasopressin Interactions in The Regulation of Cardiovascular Functions. Evidence for an Impaired Hormonal Sympathetic Reflex in Hypertension and Congestive Heart Failure
Endocrine, Metabolic & Immune Disorders - Drug Targets Mas Receptor Agonists as Novel Antihypertensive Agents
Current Hypertension Reviews Monoamino Oxidase A: An Interesting Pharmacological Target for the Development of Multi-Target QSAR
Mini-Reviews in Medicinal Chemistry Pyrrolo-isoxazole: A Key Molecule with Diverse Biological Actions
Mini-Reviews in Medicinal Chemistry What is Currently the Best Radiopharmaceutical for the Hybrid PET/CT Detection of Recurrent Medullary Thyroid Carcinoma?
Current Radiopharmaceuticals Towards A Superior Streptokinase for Fibrinolytic Therapy of Vascular Thrombosis
Cardiovascular & Hematological Agents in Medicinal Chemistry Amniotic Fluid Embolism: Review
Current Pharmaceutical Biotechnology Antiplatelet Therapy in the Prevention of Coronary Syndromes: Mode of Action, Benefits, Drawbacks
Cardiovascular & Hematological Agents in Medicinal Chemistry Hydrogen Sulfide: From Physiology to Pharmacology
Inflammation & Allergy - Drug Targets (Discontinued) CPR Technique for Infants and Children
Current Pediatric Reviews Nanocrystalline ZnO: A Competent and Reusable Catalyst for the Preparation of Pharmacology Relevant Heterocycles in the Aqueous Medium
Current Green Chemistry The Effect of Serotonin 5-HT2 Receptor Inhibitor on Vasomotor Responses
Vascular Disease Prevention (Discontinued) Weight Loss in Obesity and Metabolic Syndrome
Current Hypertension Reviews Perinatal Brain Injury
Current Pediatric Reviews Targeting the Noradrenergic System in Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis of Prazosin Trials
Current Drug Targets Catatonia: A Narrative Review
Central Nervous System Agents in Medicinal Chemistry Novel Insight into the Inflammatory and Cellular Responses Following Experimental Glaucoma Surgery: A Roadmap for Inhibiting Fibrosis
Current Molecular Medicine Antiplatelet Therapy in Children: Why So Different from Adults’?
Current Pharmaceutical Design Role of the Peroxynitrite - Poly (ADP-Ribose) Polymerase Pathway in the Pathogenesis of Liver Injury
Current Pharmaceutical Design